Evidence map›Paper›PMID 41522481›Full record

ArticleFrontiers in psychiatry2025

Neurocognitive outcomes in adolescents with and without four weeks of cannabis abstinence: a randomized clinical trial using contingency management.

Randi M Schuster, Meghan A Costello, Kevin Potter, Matteo Torquati, Jodi M Gilman, A Eden Evins

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Randi M SchusterDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Meghan A CostelloDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Kevin PotterDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Matteo TorquatiUniversity of Miami Miller School of Medicine, Miami, FL, United States.
Jodi M GilmanDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
A Eden EvinsDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As adolescent cannabis use becomes more common, questions remain about the potential for neurocognitive recovery after stopping cannabis use. Method: This study examined whether short-term abstinence from cannabis leads to cognitive improvements. A total of 238 adolescents (ages 13-19; 51% female; 55% White, 18% Black, 9% Asian, 18% other races) from Greater Boston participated, including 154 adolescents who regularly used cannabis (CB) and 84 adolescents with no cannabis use (NU). Participants who used cannabis were randomized to incentivized abstinence (CB-Abst) or a non-contingent monitoring control (CB-Mon). Non-users completed four weeks of monitoring (NU). Participants completed tests of executive function, memory, and attention weekly for four weeks. Results: At baseline, CB adolescents demonstrated worse verbal memory and processing speed than NU on (p <.006). CB-Abst performance was similar to that of the NU group at week 4. At week 4, those in the CB-Abst group showed greater improvements in inhibitory control compared to the CB-Mon group (β = -10.9, p = .037). There were no significant differences between CB groups in memory or attention task performance at week 4. Exploratory analyses revealed modest gains across all groups in some tasks. Discussion: Brief cannabis abstinence may be associated with improvements in executive function among adolescents, supporting the idea of neurocognitive recovery, which has important implications for treatment, prevention, and public health policies.

Indexed as

abstinence interventionadolescencecannabiscognitive recoverycontingency managementexecutive function

Identifiers

PMID41522481
PMCPMC12785183

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.